Interactions of hearing loss and diabetes mellitus in the middle age CBA/CaJ mouse model of presbycusis

Hearing Research

Volumn 249, Issue 1-2, 2009, Pages 44-53

  Vasilyeva, Olga N ^a,b   Frisina, Susan T ^a,b   Zhu, Xiaoxia ^a,b   Walton, Joseph P ^a,b   Frisina, Robert D ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Auditory brainstem response; Auditory midbrain; CBA CaJ mice; Diabetes; Distortion product otoacoustic emissions; Hearing loss; Inferior colliculus

Indexed keywords

AGING; ANIMALS; AUDITORY THRESHOLD; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HUMANS; INFERIOR COLLICULI; MALE; MICE; MICE, INBRED CBA; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PRESBYCUSIS;

EID: 60849085421     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2009.01.007     Document Type: Article

References (69)

1. Allen P.D., Burkard R.F., Ison J.R., and Walton J.P. Impaired gap encoding in aged mouse inferior colliculus at moderate but not high stimulus levels. Hear. Res. 186 (2003) 17-29
2. American Diabetes Association 2006. Standards of medical care in diabetes. Diabetes Care, 29, 4-42.
3. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., and Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 122 (1999) 757-768
4. Biessels G.J., Smale S., Duis S.E., Kamal A., and Gispen W.H. The effect of gamma-linoleic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J. Neurol. Sci. 182 (2001) 99-106
5. Biessels G.J., van der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 44 (2002) 1-14
6. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res. 21 (2005) 86-93
7. Caspary D.M., Raza A., Lawhorn Armour B.A., Pippin J., and Arneric S.P. Immunocytochemical and neurochemical evidence for age-related loss of GABA in the inferior colliculus: implications for neural presbycusis. J. Neurosci. 10 (1990) 2363-2372
8. Caspary D.M., Milbrandt J.C., and Helfert R.H. Central auditory aging: GABA changes in the inferior colliculus. Exp. Gerontol. 30 (1995) 349-360
9. Caspary D.M., Holder T.M., Hughes L.F., Milbrandt J.C., McKernan R.M., and Naritoku D.K. Age-related changes in GABAa receptor subunit composition and function in rat auditory system. Neuroscience 93 (1999) 307-312
10. Collin G.B., Cyr E., Bronson R., Marshall J.D., Gifford E.J., Hicks W., Murray S.A., Zheng Q.Y., Smith R.S., Nishina P.M., and Naggert J.K. Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum. Mol. Genet. 14 (2005) 2323-2333
11. Cryns K., Thys S., Van Laer L., Oka Y., Pfister M., Van Nassauw L., Smith R.J., Timmermans J.P., and Van Camp G. The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem. Cell Biol. 119 (2003) 247-256
12. Dalton D.S., Cruickshanks K.J., Klein R., Klein B.E., and Wiley T.L. Association of NIDDM and hearing loss. Diabetes Care 21 (1998) 1540-1544
13. de Espana R., Biurrun O., Lorente J., and Traserra J. Hearing and diabetes. ORL J. Otorhinolaryngol Relat. Spec. 57 (1995) 325-327
14. Di Leo M.A., Di Nardo W., Cercone S., Ciervo A., Lo Monaco M., Greco A.V., Paludetti G., and Ghirlanda G. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care 20 (1997) 824-828
15. Diaz de Leon-Morales L.V., Jauregui-Renaud K., Garay-Sevilla M.E., Hernandez-Prado J., and Malacara-Hernandez J.M. Auditory impairment in patients with type 2 diabetes mellitus. Arch. Med. Res. 36 (2005) 507-510
16. Donald M.W., Bird C.E., Lawson J.S., Letemendia F.J., Monga T.N., Surridge D.H., Varette-Cerre P., Williams D.L., Williams D.M., and Wilson D.L. Delayed auditory brainstem responses in diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 44 (1981) 641-644
17. Elamin A., Fadlallah M., and Tuevmo T. Hearing loss in children with type 1 diabetes. Indian Pediatr. 42 (2005) 15-21
18. Erdem T., Ozturan O., Miman M.C., Ozturk C., and Karatas E. Exploration of the early auditory effects of hyperlipoproteinemia and diabetes mellitus using otoacoustic emissions. Eur. Arch. Otorhinolaryngol. 260 (2003) 62-66
19. Ferrer J.P., Biurrun O., Lorente J., Conget J.I., de Espana R., Esmatjes E., and Gomis R. Auditory function in young patients with type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 11 (1991) 17-22
20. Fowler P.D., and Jones N.S. Diabetes and hearing loss. Clin. Otolaryngol. 24 (1999) 3-8
21. Frisina R.D., and Walton J.P. Age-related structural and functional changes in the cochlear nucleus. Hear. Res. 217 (2006) 216-233
22. Frisina R.D., Walton J.P., Lynch-Armour M.A., and Byrd J.D. Inputs to a physiologically characterized region of the inferior colliculus of the young adult CBA mouse. Hear Res. 115 (1998) 61-81
23. Frisina S.T., Mapes F., Kim S., Frisina D.R., and Frisina R.D. Characterization of hearing loss in aged type II diabetics. Hear. Res. 211 (2006) 103-113
24. Fukushima H., Cureoglu S., Schachern P.A., Kusunoki T., Oktay M.F., Fukushima N., Paparella M.M., and Harada T. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol. Head Neck Surg. 133 (2005) 100-106
25. Fukushima H., Cureoglu S., Schachern P.A., Paparella M.M., Harada T., and Oktay M.F. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch. Otolaryngol. Head. Neck. Surg. 132 (2006) 934-938
26. Gates G.A., and Mills J.H. Presbycusis. Lancet 366 (2005) 1111-1120
27. Gratton M.A., and Vazquez A.E. Age-related hearing loss: current research. Curr. Opin. Otolaryngol. Head. Neck Surg. 11 (2003) 367-371
28. Guimaraes P., Zhu X., Cannon T., Kim S., and Frisina R.D. Sex differences in distortion product otoacoustic emissions as a function of age in CBA mice. Hear. Res. 192 (2004) 83-89
29. Henry K.R. Sex- and age-related elevation of cochlear nerve envelope response (CNER) and auditory brainstem response (ABR) thresholds in C57BL/6 mice. Hear. Res. 170 (2002) 107-115
30. Henry K.R., and Price J.M. Amplitude enhancement is seen in the cochlear nerve but not at, or before, the afferent synapse. Hear. Res. 79 (1994) 190-196
31. Hsueh W., Abel E.D., Breslow J.L., Maeda N., Davis R.C., Fisher E.A., Dansky H., McClain D.A., McIndoe R., Wassef M.K., Rabadán-Diehl C., and Goldberg I.J. Recipes for creating animal models of diabetic cardiovascular disease. Circ. Res. 100 (2007) 1415-1427
32. Ishikawa T., Naito Y., and Taniguchi K. Hearing impairment in WBN/Kob rats with spontaneous diabetes mellitus. Diabetologia 38 (1995) 649-655
33. Jacobson M., Kim S., Romney J., Zhu X., and Frisina R.D. Contralateral suppression of distortion-product otoacoustic emissions declines with age: a comparison of findings in CBA mice with human listeners. Laryngoscope 113 (2003) 1707-1713
34. Johnson K.R., Zheng Q.Y., and Noben-Trauth K. Strain background effects and genetic modifiers of hearing in mice. Brain Res. 1091 (2006) 79-88
35. Kim S.-H., Frisina D.R., and Frisina R.D. Effects of age on contralateral suppression of distortion product otoacoustic emissions in human listeners with normal hearing. Audiol. Neurootol. 7 (2002) 348-357
36. Kurien M., Thomas K., and Bhanu T.S. Hearing threshold in patients with diabetes mellitus. J. Laryngol. Otol. 103 (1989) 164-168
37. Liberman M.C., Tartaglini E., Fleming J.C., and Neufeld E.J. Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype. J. Assoc. Res. Otolaryngol. 7 (2006) 211-217
38. Maia C.A., and Campos C.A. Diabetes mellitus as etiological factor of hearing loss. Bras. Otorhinolaryngol. (Engl. Ed.) 71 (2005) 208-214
39. Manschot .S.M., Gispen W.H., Kappelle L.J., and Biessels G.J. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor. Diabetes Metab. Res. Rev. 19 (2003) 469-477
40. McQueen C.T., Baxter A., Smith T.L., Raynor E., Yoon S.M., Prazma J., and Pillsbury III H.C. Non-insulin-dependent diabetic microangiopathy in the inner ear. J. Laryngol. Otol. 113 (1999) 13-18
41. Mordes J.P., and Rossini A.A. Animal models of diabetes. Am. J. Med. 70 (1981) 353-360
42. Nageris B., Hadar T., Feinmesser M., and Elidan J. Cochlear histopathologic analysis in diabetic rats. Am. J. Otol. 19 (1998) 63-65
43. Nakae S., and Tachibana M. The cochlea of the spontaneously diabetic mouse. II. electron microscopic observations of non-obese diabetic mice. Arch. Otorhinolaryngol. 243 (1986) 313-316
44. Notvest R.R., and Inserra J.J. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats. Diabetes 36 (1987) 500-504
45. Paik S.G., Fleischer N., and Shin S.I. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc. Natl. Acad. Sci. USA 77 (1980) 6129-6133
46. Parham K., Sun X.M., and Kim D.O. Distortion product otoacoustic emissions in the CBA/J mouse model of presbycusis. Hear. Res. 134 (1999) 29-38
47. Parving A., Elberling C., Balle V., Parbo J., Dejgaard A., and Parving H.H. Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology 29 (1990) 113-121
48. Raynor E.M., Carrasco V.N., Prazma J., and Pillsbury H.C. An assessment of cochlear hair-cell loss in insulin-dependent diabetes mellitus diabetic and noise-exposed rats. Arch. Otolaryngol. Head. Neck. Surg. 121 (1995) 452-456
49. Rózańska-Kudelska M., Chodynicki S., Kinalska I., and Kowalska I. Hearing loss in patients with diabetes mellitus type II. Otolaryngol. Pol. 56 (2002) 607-610
50. Rubini R., Biasiolo F., Fogarolo F., Magnavita V., Martini A., and Fiori M.G. Brainstem auditory evoked potentials in rats with streptozotocin-induced diabetes. Diabetes Res. Clin. Pract. 16 (1992) 19-25
51. Rust K.R., Prazma J., Triana R.J., Michaelis IV O.E., and Pillsbury H.C. Inner ear damage secondary to diabetes mellitus. II. Changes in aging SHR/N-cp rats. Arch. Otolaryngol. Head Neck Surg. 118 (1992) 397-400
52. Sakuta H., Suzuki T., Yasuda H., and Ito T. Type 2 diabetes and hearing loss in personnel of the Self-Defense Forces. Diabetes Res. Clin. Pract. 75 (2007) 229-234
53. Salvinelli F., Miele A., Casale M., Greco F., D'Ascanio L., Firrisi L., Trivelli M., Petitti T., Aloe L., and Pozzilli P. Hearing thresholds in patients with diabetes. Int. J. Otorhinolaryngol. 3 (2004) 1-8
54. Sasso F.C., Salvatore T., Tranchino G., Cozzolino D., Caruso A.A., Persico M., Gentile S., Torella D., and Torella R. Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia. Metabolism 48 (1999) 346-350
55. Shafrir E. Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models. In: Porte Jr. D., and Sherwin R.S. (Eds). Ellenberg and Rifkin's diabetes mellitus; theory and practice. fifth ed. (1997), Appleton & Lange, Stamford 301-348
56. Smith T.L., Raynor E., Prazma J., Buenting J.E., and Pillsbury H.C. Insulin-dependent diabetic microangiopathy in the inner ear. Laryngoscope 105 (1995) 236-240
57. Spongr V.P., Flood D.G., Frisina R.D., and Salvi R.J. Quantitative measures of hair cell loss in CBA and C57BL/6 mice throughout their life spans. J. Acoust. Soc. Am. 101 (1997) 3546-3553
58. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
59. Tadros S.F., D'Souza M., Zettel M.L., Zhu X., Lynch-Erhardt M., and Frisina R.D. Serotonin 2B receptor: upregulated with age and hearing loss in mouse auditory system. Neurobiol. Aging 28 (2007) 1112-1123
60. Tay H.L., Ray N., Ohri R., and Frootko N.J. Diabetes mellitus and hearing loss. Clin. Otolaryngol. Allied Sci. 20 (1995) 130-134
61. Taylor I.G., and Irwin J. Some audiological aspects of diabetes mellitus. J. Laryngol. Otol. 92 (1978) 99-113
62. Triana R.J., Suits G.W., Garrison S., Prazma J., Brechtelsbauer P.B., Michaelis O.E., and Pillsbury H.C. Inner ear damage secondary to diabetes mellitus. I. Changes in adolescent SHR/N-cp rats. Arch. Otolaryngol. Head Neck Surg. 117 (1991) 635-640
63. Wade G.N., Gray J.M., and Bartness T.J. Gonadal influences on adiposity. Int. J. Obes. 9 Suppl. 1 (1985) 83-92
64. Walton J.P., Frisina R.D., and O'Neill W.E. Age-related alteration in neural processing of silent gaps in the central nucleus of the inferior colliculus in the CBA mouse model of presbycusis. J. Neurosci. 18 (1998) 2764-2776
65. Willott J.F., and Carlson S. Modification of the acoustic startle response in hearing-impaired C57BL/6J mice: prepulse augmentation and prolongation of prepulse inhibition. Behav. Neurosci. 109 (1995) 396-403
66. Willott J.F., Carlson S., and Chen H. Prepulse inhibition of the startle response in mice: relationship to hearing loss and auditory system plasticity. Behav. Neurosci. 108 (1994) 703-713
67. Willott J.F., Chisolm T.H., and Lister J.J. Modulation of presbycusis: current status and future directions. Audiol. Neurootol. 6 (2001) 231-249
68. Zhang L., Reidy S.P., Nicholson T.E., Lee H.J., Majdalawieh A., Webber C., Stewart B.R., Dolphin P., and Ro H.S. The role of AEBP1 in sex-specific diet-induced obesity. Mol. Med. 11 (2005) 39-47
69. Zhu X., Vasilyeva O.N., Kim S., Jacobson M., Romney J., Waterman M.S., Tuttle D., and Frisina R.D. Auditory efferent feedback system deficits precede age-related hearing loss: Contralateral suppression of otoacoustic emissions in mice. J. Comp. Neurol. 10 (2007) 593-604